Fripan Injection (Butylscopolamine Bromide)

Adult administration

As butylscopolamine bromide, 10 to 20 mg is administered subcutaneously, intramuscularly, or intravenously. Adjust dosage appropriately according to age and symptoms.

This medication may cause serious allergic reactions such as anaphylaxis after injection, so patients should be monitored closely after administration. Care should be taken when using ampoules, as glass fragments may be present, and caution is especially necessary when administering to children or the elderly. This medication should not be administered to patients with certain diseases, such as glaucoma, prostate enlargement, gastrointestinal obstruction, myasthenia gravis, or cardiovascular diseases. Patients on anticoagulants may develop hematomas if this medication is administered intramuscularly, thus it should only be given subcutaneously or intravenously. Patients with bacterial diarrhea or those with heart disease or hyperthyroidism should exercise caution when using this medication. Due to its anticholinergic effect, this medication can cause side effects such as dry mouth, constipation, urinary problems, headaches, drowsiness, dizziness, palpitations, and sweating disorders. During administration, visual disturbances, drowsiness, or dizziness may occur, so driving or operating dangerous machinery should be avoided. Patients with glaucoma should consult an ophthalmologist immediately if they experience eye pain or vision impairment after using this medication. Caution should be exercised if used in combination with other anticholinergic drugs or certain antidepressants and antihistamines, as side effects may be intensified. Women who are pregnant or breastfeeding should use this medication carefully after consulting a doctor due to the lack of established safety. Elderly patients should be especially careful when using this medication as prostate enlargement is common in this demographic. In case of overdose, anticholinergic symptoms may manifest, and appropriate treatment such as the administration of parasympathomimetic agents may be necessary. When administering intravenously, inject slowly, and ensure there is no tissue damage when giving subcutaneously or intramuscularly. This medication should be stored in a container that blocks light at room temperature, and proper storage conditions should be observed.

Serious side effects

• Anaphylactic shock
• anaphylactic reaction
• difficulty breathing.

Mild side effects

• Dry mouth
• thirst
• nausea
• vomiting
• constipation
• mydriasis
• muscle paralysis
• visual accommodation disorder
• headache
• heaviness of the head

This medication is sensitive to light and should be stored in a tightly closed container that blocks light. Additionally, it should be kept in a place that is not too hot or too cold, safely at normal room temperature.

Appearance

Colorless transparent liquid in brown ampoule injection

Package unit

50 ampoules/box [1 milliliter/ampoule * 50]